Cargando…
Concurrent suppression of Aβ aggregation and NLRP3 inflammasome activation for treating Alzheimer's disease
Alzheimer's disease (AD) is a neurodegenerative illness accompanied by severe memory loss, cognitive disorders and impaired behavioral ability. Amyloid β-peptide (Aβ) aggregation and nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome play crucial roles...
Autores principales: | Yang, Tao, Zhang, Lei, Shang, Yicun, Zhu, Zhenzhu, Jin, Suxing, Guo, Zijian, Wang, Xiaoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905858/ https://www.ncbi.nlm.nih.gov/pubmed/35382471 http://dx.doi.org/10.1039/d1sc06071f |
Ejemplares similares
-
Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation
por: Yang, Tao, et al.
Publicado: (2019) -
Inhibition of metal-induced amyloid β-peptide aggregation by a blood–brain barrier permeable silica–cyclen nanochelator
por: Wang, Jinzhuan, et al.
Publicado: (2019) -
Alzheimer's Therapeutic Strategy: Photoactive Platforms for Suppressing the Aggregation of Amyloid β Protein
por: Li, Chenglong, et al.
Publicado: (2020) -
Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism
por: Zhu, Zhenzhu, et al.
Publicado: (2019) -
Regulating tumor glycometabolism and the immune microenvironment by inhibiting lactate dehydrogenase with platinum(iv) complexes
por: Jin, Suxing, et al.
Publicado: (2023)